ANGO Financial Facts
Net sales: 88.1MBasic weighted average shares outstanding: 36.32M
See Full Income Statement
Current portion of long-term debt: 17.5M
Prepaid expenses and other: 4.26M
See Full Balance Sheet
AngioDynamics (ANGO) Earnings
|
Expand Research on ANGO
| Next EPS Date | 7/10/24 *Est. | EPS Growth Rate | -433.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +7.7% | Revenue Growth Rate | -18.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/4/24 | Q324 | -$0.16 | -$0.14 | -$0.02 | $66M | $75.73M |  |
 | | Details | |
| 1/5/24 | Q224 | -$0.05 | -$0.08 | +$0.03 | $79.1M | $81.97M | |
| | Details | |
| 10/4/23 | Q124 | -$0.12 | -$0.13 | +$0.01 | $78.7M | $77.69M | |
| | Details | |
| 7/12/23 | Q423 | $0.02 | $0.02 | $0.00 | $91.1M | $90.74M | |
| | Details | |
| 3/30/23 | Q323 | -$0.03 | -$0.01 | -$0.02 | $80.7M | $83.2M | = | | | Details | |
| 1/5/23 | Q223 | $0.01 | -$0.01 | +$0.02 | $85.4M | $84.38M | = | | | Details | |
| 10/6/22 | Q123 | -$0.06 | -$0.02 | -$0.04 | $81.5M | $82.58M | = | | | Details | |
| 7/12/22 |  |
Q422 | $0.01 | $0.01 | $0.00 | $87M | $82.92M | = | | | Details |
